BR9812525A - Proteinase degradadora de complemento humano c3 de streptococcus pneumoniae - Google Patents
Proteinase degradadora de complemento humano c3 de streptococcus pneumoniaeInfo
- Publication number
- BR9812525A BR9812525A BR9812525-7A BR9812525A BR9812525A BR 9812525 A BR9812525 A BR 9812525A BR 9812525 A BR9812525 A BR 9812525A BR 9812525 A BR9812525 A BR 9812525A
- Authority
- BR
- Brazil
- Prior art keywords
- human complement
- proteinase
- streptococcus pneumoniae
- degrading
- degrading proteinase
- Prior art date
Links
- 102000035195 Peptidases Human genes 0.000 title abstract 5
- 108091005804 Peptidases Proteins 0.000 title abstract 5
- 235000019833 protease Nutrition 0.000 title abstract 5
- 230000000295 complement effect Effects 0.000 title abstract 3
- 230000000593 degrading effect Effects 0.000 title abstract 3
- 241000193998 Streptococcus pneumoniae Species 0.000 title abstract 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 title abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Patente de Invenção: <B>"PROTEINASE DEGRADADORA DE COMPLEMENTO HUMANO C3 DE STREPTOCOCCUS PNEUMONIAE"<D>. A presente invenção refere-se à identificação e ao uso de uma família de proteinases degradadoras de complemento humano C3, expressadas por S. pneumoniae. A proteinase tem um peso molecular de cerca de 15 kDa a cerca de 25 kDa. Uma proteinase preferida desta invenção inclui a seq³ência de aminoácidos de SEQ ID NO: 2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5990797P | 1997-09-24 | 1997-09-24 | |
PCT/US1998/020186 WO1999015675A1 (en) | 1997-09-24 | 1998-09-24 | HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9812525A true BR9812525A (pt) | 2000-07-25 |
Family
ID=22026061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9812525-7A BR9812525A (pt) | 1997-09-24 | 1998-09-24 | Proteinase degradadora de complemento humano c3 de streptococcus pneumoniae |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1017828A1 (pt) |
JP (1) | JP2001517449A (pt) |
KR (1) | KR20010024299A (pt) |
CN (1) | CN1291233A (pt) |
AU (1) | AU9510598A (pt) |
BR (1) | BR9812525A (pt) |
CA (1) | CA2305016A1 (pt) |
WO (1) | WO1999015675A1 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245335B1 (en) | 1996-05-01 | 2001-06-12 | The Rockefeller University | Choline binding proteins for anti-pneumococcal vaccines |
DE69737125T3 (de) | 1996-10-31 | 2015-02-26 | Human Genome Sciences, Inc. | Streptococcus pneumoniae-Antigene und Impfstoffe |
US6676943B1 (en) | 1997-04-24 | 2004-01-13 | Regents Of The University Of Minnesota | Human complement C3-degrading protein from Streptococcus pneumoniae |
EP1790729A3 (en) * | 1998-07-27 | 2007-07-25 | Sanofi Pasteur Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
US6936252B2 (en) | 1998-07-27 | 2005-08-30 | Microbial Technics Limited | Streptococcus pneumoniae proteins and nucleic acid molecules |
EP1115875A1 (en) * | 1998-09-24 | 2001-07-18 | Regents Of The University Of Minnesota | Human complement c3-degrading polypeptide from streptococcus pneumoniae |
ATE422899T1 (de) | 1998-12-21 | 2009-03-15 | Medimmune Inc | Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe |
AU2005209689B2 (en) * | 1998-12-23 | 2008-07-17 | Id Biomedical Corporation Of Quebec | Novel streptococcus antigens |
TR200200633T2 (tr) * | 1998-12-23 | 2002-06-21 | Shire Biochem Inc. | Yeni streptococcus antijenleri |
US7128918B1 (en) | 1998-12-23 | 2006-10-31 | Id Biomedical Corporation | Streptococcus antigens |
EP1950302B1 (en) * | 1998-12-23 | 2012-12-05 | ID Biomedical Corporation of Quebec | Streptococcus antigens |
CA2413450C (en) * | 2000-06-20 | 2014-02-18 | Shire Biochem Inc. | Streptococcus antigens |
US7074415B2 (en) | 2000-06-20 | 2006-07-11 | Id Biomedical Corporation | Streptococcus antigens |
GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
EP1355918B9 (en) * | 2000-12-28 | 2012-01-25 | Wyeth LLC | Recombinant protective protein from $i(streptococcus pneumoniae) |
US7262024B2 (en) | 2001-12-20 | 2007-08-28 | Id Biomedical Corporation | Streptococcus antigens |
WO2007047995A2 (en) * | 2005-10-21 | 2007-04-26 | Catalyst Biosciences, Inc. | Modified proteases that inhibit complement activation |
TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
EP3020411A1 (en) | 2005-12-22 | 2016-05-18 | GlaxoSmithKline Biologicals s.a. | Vaccine |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
WO2009000825A2 (en) | 2007-06-26 | 2008-12-31 | Glaxosmithkline Biologicals S.A. | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
EA201001479A1 (ru) | 2008-04-16 | 2011-06-30 | Глаксосмитклайн Байолоджикалс С.А. | Вакцина |
GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
GB201003920D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
WO2012156391A1 (en) | 2011-05-17 | 2012-11-22 | Glaxosmithkline Biologicals S.A. | Vaccine against streptococcus pneumoniae |
CN102731739B (zh) * | 2012-07-05 | 2013-11-06 | 富阳经略化工技术有限公司 | 用作润滑油粘度指数改进剂的星形聚合物及其制备方法和应用 |
GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69737125T3 (de) * | 1996-10-31 | 2015-02-26 | Human Genome Sciences, Inc. | Streptococcus pneumoniae-Antigene und Impfstoffe |
CN1253589A (zh) * | 1997-04-24 | 2000-05-17 | 美国明尼苏达州大学 | 来自肺炎链球菌的降解人类补体c3的蛋白酶 |
-
1998
- 1998-09-24 CN CN98809460A patent/CN1291233A/zh active Pending
- 1998-09-24 WO PCT/US1998/020186 patent/WO1999015675A1/en not_active Application Discontinuation
- 1998-09-24 JP JP2000512965A patent/JP2001517449A/ja active Pending
- 1998-09-24 AU AU95105/98A patent/AU9510598A/en not_active Abandoned
- 1998-09-24 KR KR1020007003198A patent/KR20010024299A/ko not_active Application Discontinuation
- 1998-09-24 CA CA002305016A patent/CA2305016A1/en not_active Abandoned
- 1998-09-24 BR BR9812525-7A patent/BR9812525A/pt not_active Application Discontinuation
- 1998-09-24 EP EP98948557A patent/EP1017828A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
KR20010024299A (ko) | 2001-03-26 |
EP1017828A1 (en) | 2000-07-12 |
WO1999015675A1 (en) | 1999-04-01 |
AU9510598A (en) | 1999-04-12 |
CN1291233A (zh) | 2001-04-11 |
CA2305016A1 (en) | 1999-04-01 |
JP2001517449A (ja) | 2001-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9812525A (pt) | Proteinase degradadora de complemento humano c3 de streptococcus pneumoniae | |
BR9914066A (pt) | Polipeptìdio degradador de c3 de complemento humano de streptococcus pneumoniae | |
EP1484339A3 (en) | Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same | |
BR9714358A (pt) | Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos | |
DE60043620D1 (de) | Mage-a1 peptide die von klasse ii hla molekule presentiert werden | |
GR3022052T3 (en) | Dna sequences which code for virulence characteristics of --(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by --(s. suis) in mammals, including man | |
MXPA03005386A (es) | Proteina protectora recombinante de streptococcus pneumoniae. | |
WO2003048205A3 (fr) | Proteines a activite inhibitrice de l'il-6 | |
WO2002062304A3 (de) | Kosmetische und/oder pharmazeutische mittel acylierte aminosäure und proteinkondensat enthaltend. | |
NZ526879A (en) | Genes and proteins, and their use | |
WO1999009054A3 (en) | Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders | |
AU2001248822A1 (en) | Gd3-mimetic peptides | |
BR9809405A (pt) | Proteinase de streptococcus pneumoniae que degrada complemento humano c3 | |
EE05139B1 (et) | Peptiid, seda kodeeriv geen, reagent ja reaktiivikomplekt riketsioosi tuvastamiseks ning peptiidi sisaldav vaktsiin | |
WO1999058638A3 (en) | Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections | |
ATE452903T1 (de) | Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten | |
WO2003095604A3 (en) | Purified peptide deformylase from streptococcus pneumoniae | |
WO2004013167A3 (en) | Purified polypeptides from enterococcus faecalis | |
WO2004011638A3 (en) | Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures | |
ATE280782T1 (de) | Serinprotease-inhibitor | |
WO2003027274A3 (en) | Purified polypeptides from pseudomonas aeruginosa | |
ATE286535T1 (de) | Regulatorisches protein pke 83 aus humanen keratinozyten | |
WO2001049722A3 (en) | New actinobacillus pleuropneumoniae outer membrane protein and its uses | |
WO2004041856A3 (en) | Crystal structures of bacterial inorganic pyrophosphatases | |
WO2002008393A3 (en) | Serine protease from yersinia enterocolitica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |